116 related articles for article (PubMed ID: 9669800)
1. Why hereditary nonpolyposis colorectal carcinoma patients appear to have better survival than patients with sporadic colorectal carcinoma.
Levin B
Cancer; 1998 Jul; 83(2):201-3. PubMed ID: 9669800
[No Abstract] [Full Text] [Related]
2. Why hereditary nonpolyposis colorectal carcinoma patients appear to have better survival than patients with sporadic colorectal carcinoma.
Sheikh RA; Min BH; Teplitz R; Tesluk H; Ruebner BH; Lawson MJ
Cancer; 1999 Jan; 85(1):253-4. PubMed ID: 9922005
[No Abstract] [Full Text] [Related]
3. Prolonged survival in hereditary nonpolyposis colorectal cancer.
Tomoda H; Baba H; Akazawa K
Oncol Rep; 1999; 6(2):321-4. PubMed ID: 10022997
[TBL] [Abstract][Full Text] [Related]
4. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members.
Watson P; Lin KM; Rodriguez-Bigas MA; Smyrk T; Lemon S; Shashidharan M; Franklin B; Karr B; Thorson A; Lynch HT
Cancer; 1998 Jul; 83(2):259-66. PubMed ID: 9669808
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer, survival advantage, and hereditary nonpolyposis colorectal carcinoma.
Lynch HT; Smyrk T
Gastroenterology; 1996 Mar; 110(3):943-54. PubMed ID: 8608906
[No Abstract] [Full Text] [Related]
6. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer.
Bertario L; Russo A; Sala P; Eboli M; Radice P; Presciuttini S; Andreola S; Rodriguez-Bigas MA; Pizzetti P; Spinelli P
Int J Cancer; 1999 Jan; 80(2):183-7. PubMed ID: 9935197
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study.
Brixen LM; Bernstein IT; Bülow S; Ehrnrooth E
Colorectal Dis; 2013 Jul; 15(7):816-23. PubMed ID: 23350633
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine differentiation in sporadic CRC and hereditary nonpolyosis colorectal cancer.
Sun MH
Dis Markers; 2004; 20(4-5):283-8. PubMed ID: 15528794
[TBL] [Abstract][Full Text] [Related]
10. The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration.
Takemoto N; Konishi F; Yamashita K; Kojima M; Furukawa T; Miyakura Y; Shitoh K; Nagai H
Jpn J Clin Oncol; 2004 Feb; 34(2):90-8. PubMed ID: 15067103
[TBL] [Abstract][Full Text] [Related]
11. Comparison of long-term outcomes between Lynch sydrome and sporadic colorectal cancer: a propensity score matching analysis.
Xu Y; Li C; Zheng CZ; Zhang YQ; Guo TA; Liu FQ; Xu Y
BMC Cancer; 2021 Jan; 21(1):45. PubMed ID: 33422027
[TBL] [Abstract][Full Text] [Related]
12. Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables.
Johannsdottir JT; Bergthorsson JT; Gretarsdottir S; Kristjansson AK; Ragnarsson G; Jonasson JG; Egilsson V; Ingvarsson S
Anticancer Res; 1999; 19(3A):1821-6. PubMed ID: 10470121
[TBL] [Abstract][Full Text] [Related]
13. [Deletion of the long arm of chromosome 18--a reliable prognostic factor in colorectal carcinoma?].
Klump B; Porschen R
Z Gastroenterol; 1995 Nov; 33(11):677-8. PubMed ID: 8600666
[No Abstract] [Full Text] [Related]
14. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer.
Renkonen-Sinisalo L; Aarnio M; Mecklin JP; Järvinen HJ
Cancer Detect Prev; 2000; 24(2):137-42. PubMed ID: 10917133
[TBL] [Abstract][Full Text] [Related]
15. [Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
Wullen B; Mühlhöfer A; Zoller WG
Z Gastroenterol; 2001 Nov; 39(11):981-4. PubMed ID: 11778159
[No Abstract] [Full Text] [Related]
16. Varying features of early age-of-onset "sporadic" and hereditary nonpolyposis colorectal cancer patients.
Guillem JG; Puig-La Calle J; Cellini C; Murray M; Ng J; Fazzari M; Paty PB; Quan SH; Wong WD; Cohen AM
Dis Colon Rectum; 1999 Jan; 42(1):36-42. PubMed ID: 10211518
[TBL] [Abstract][Full Text] [Related]
17. Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer.
Haghighi MM; Vahedi M; Mohebbi SR; Pourhoseingholi MA; Fatemi SR; Zali MR
Asian Pac J Cancer Prev; 2009; 10(2):209-12. PubMed ID: 19537885
[TBL] [Abstract][Full Text] [Related]
18. Molecular markers of prognosis in colorectal cancer.
Nicholl ID; Dunlop MG
J Natl Cancer Inst; 1999 Aug; 91(15):1267-9. PubMed ID: 10433607
[No Abstract] [Full Text] [Related]
19. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients.
Stigliano V; Assisi D; Cosimelli M; Palmirotta R; Giannarelli D; Mottolese M; Mete LS; Mancini R; Casale V
J Exp Clin Cancer Res; 2008 Sep; 27(1):39. PubMed ID: 18803843
[TBL] [Abstract][Full Text] [Related]
20. Concepts in familial colorectal cancer: where do we stand and what is the future?
Castells A; Castellví-Bel S; Balaguer F
Gastroenterology; 2009 Aug; 137(2):404-9. PubMed ID: 19540838
[No Abstract] [Full Text] [Related]
[Next] [New Search]